$40.00
In stock
BPC-157 TB-500 10mg is a dual-component laboratory research material containing 5mg BPC-157 and 5mg TB-500 fragment in a single lyophilized preparation. The combined format provides a standardized material for controlled investigation of cellular signaling, cytoskeletal organization, and related biochemical pathway models.
This laboratory research material combines BPC-157 and the TB-500 (Thymosin Beta-4) fragment into a single lyophilized preparation totaling 20 mg. The combination is of interest to researchers examining two structurally distinct biomolecules within tissue-related laboratory models and provides a convenient single-vial format for comparative or combined in vitro study designs.
BPC-157 is a synthetic 15-amino-acid sequence that has been investigated in laboratory models involving cellular signaling, angiogenesis-associated pathways, and gastrointestinal biochemical interactions. The TB-500 fragment, derived from Thymosin Beta-4, has been studied in the context of actin-associated interactions, cytoskeletal organization, cellular migration, and structural remodeling pathways. Their combined format provides a basis for laboratory investigation of interactions between these distinct biochemical research pathways.
BPC-157 consists of a 15-amino-acid sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) with a molecular weight of approximately 1419 g/mol and a molecular formula of C₆₂H₉₈N₁₆O₂₂. The TB-500 fragment is an acetylated sequence (Ac-Ser-Asp-Lys-Pro-Ala-Asp-Met-Ala-Glu-Ile-Gln-Glu-Lys-Phe-Asp-Lys-Glu) characterized for laboratory investigation involving actin-associated and cytoskeletal research models.
Explore additional laboratory research materials available from Top Tier Science.
This product is intended exclusively for laboratory and scientific research purposes. It is not intended for human or veterinary use, and no claims are made regarding its safety, efficacy, or suitability for any therapeutic, diagnostic, or consumer application.